NUS-Led Study: Consumption of A Bioactive Compound From Neem Plant Could Significantly Suppress Development Of Prostate Cancer

Congratulation to Associate Professor Gautam Sethi from the Department of Pharmacology at the Yong Loo Lin School of Medicine, who led a team of international researchers, at the National University of Singapore (NUS), has found that nimbolide, a bioactive terpenoid compound derived from Azadirachta indica or more commonly known as the neem plant, could reduce the size of prostate tumour by up to 70 per cent and suppress its spread or metastasis by half.

Leave a Comment

Your email address will not be published. Required fields are marked *